New technique to heal venous ulcers: terminal interruption of the reflux source (TIRS)
- PMID: 21098501
- DOI: 10.1177/1531003510387637
New technique to heal venous ulcers: terminal interruption of the reflux source (TIRS)
Abstract
Background: Treatment of healing venous ulcers continues to be a challenge; currently used techniques, as adjuncts to compression therapy aid to prevent recurrence but fail to heal ulcers.
Method: A technique of terminal interruption of the reflux source (TIRS) was used. The TIRS procedure targets the terminal source of reflux. The purpose of the procedure is to temporarily reduce the venous hypertension at the local level, thus allowing healing to occur. By ultrasound guidance, 1% Sotradecol foam is injected into a venous branch or branches in close proximity to the ulcer bed. The branch may course under the ulcer or lead directly to it. Although more than one outflow source may be localized, all targeted veins must have documentation of reflux and have continuity with the primary source.
Results: To date, 14 patients have been treated. All had long-standing ulcers, 6 months to 2 years, and had been compliant with compression therapy. All patients were CEAP (clinical, etiologic, anatomic, pathophysiologic) class 6 with a venous clinical severity score ranging from 12 to 22. Rapid healing of all venous ulcers with an average time to ulcer healing of 6 to 8 weeks has been achieved. In all, 7 patients are ulcer free at 5 years, 4 patients are ulcer free for more than 2 years, 2 patients are ulcer free at 1 year, and 1 patient is undergoing treatment on remaining ulcers.
Conclusion: TIRS is a safe and effective treatment to heal venous ulcers. Local reduction of venous hypertension is the underlying factor for promoting rapid healing. More studies and careful documentation will likely prove the validity of this treatment regime.
Similar articles
-
Profuse bleeding in patients with chronic venous insufficiency.Int Angiol. 2007 Mar;26(1):64-6. Int Angiol. 2007. PMID: 17353890
-
Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux.J Vasc Surg. 2014 May;59(5):1368-76. doi: 10.1016/j.jvs.2013.11.007. Epub 2014 Jan 6. J Vasc Surg. 2014. PMID: 24406088 Free PMC article.
-
The effect of percutaneous intervention on wound healing in patients with mixed arterial venous disease.Ann Vasc Surg. 2011 Jan;25(1):79-86. doi: 10.1016/j.avsg.2010.09.006. Ann Vasc Surg. 2011. PMID: 21172582
-
Medical and surgical therapy for advanced chronic venous insufficiency.Surg Clin North Am. 2010 Dec;90(6):1195-214. doi: 10.1016/j.suc.2010.08.008. Surg Clin North Am. 2010. PMID: 21074036 Review.
-
Wound Healing Society (WHS) venous ulcer treatment guidelines: what's new in five years?Wound Repair Regen. 2012 Sep-Oct;20(5):619-37. doi: 10.1111/j.1524-475X.2012.00815.x. Epub 2012 Jul 16. Wound Repair Regen. 2012. PMID: 22805581 Review.
Cited by
-
No More Venous Ulcers-What More Can We Do?J Clin Med. 2023 Sep 23;12(19):6153. doi: 10.3390/jcm12196153. J Clin Med. 2023. PMID: 37834797 Free PMC article. Review.
-
Current Best Practice in the Management of Varicose Veins.Clin Cosmet Investig Dermatol. 2022 Apr 6;15:567-583. doi: 10.2147/CCID.S294990. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35418769 Free PMC article. Review.
-
Axial ablation versus terminal interruption of the reflux source (AAVTIRS): a randomised controlled trial.Trials. 2022 Jun 10;23(1):483. doi: 10.1186/s13063-022-06440-4. Trials. 2022. PMID: 35689289 Free PMC article. Clinical Trial.
-
Axial Ablation versus Terminal Interruption of the Reflux Source (AAVTIRS): A Randomised Controlled Trial.Vasc Endovascular Surg. 2024 Nov;58(8):805-812. doi: 10.1177/15385744241265750. Epub 2024 Jul 21. Vasc Endovascular Surg. 2024. PMID: 39034428 Free PMC article. Clinical Trial.